Automated three-dimensional total-body photography improves the efficiency of positive malignant biopsies and reduces ...

BPDCN is an aggressive hematologic malignancy with a historically poor prognosis VisualDx is a clinical decision support system used by more than 2,300 hospitals, clinics, and medical schools around ...

The precision cancer business of PHC Holdings anticipates an increase in cancer cases and is expanding its digital pathology and immunohistochemistry instrument lineup.

BioMérieux obtained 510 (k) clearance last year for its Vitek Reveal ID/AST system as part of its current five-year growth plan.

StockNews.com initiated coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Free Report) in a report released on Monday morning. The firm issued a hold rating on the medical research company’s ...

MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery ...

Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the Daxor Corporation Conference ...

building on the authorization of five panels for use on the QIAstat-Dx system in the last 10 months. With the latest development, QIAGEN now has regulatory clearances for three mini panels for the ...

It also builds on the authorisation of five panels for use on the QIAstat-Dx system in the past ten months. The company has secured regulatory approvals for three mini panels designed to detect ...

It also builds on the authorisation of five panels for use on the QIAstat-Dx system in the past ten months. The company has secured regulatory approvals for three mini panels designed to detect ...